Table of Contents
Volume 6 | Issue 2
Publication Date: September 2004- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Researches in Brief | ||
74-76 |
Early Clinical Data with Small-Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitors G. Kesava Reddy, Sakkariappan Ramalingam, Vinay K. Jain |
|
79-82 |
Impact of Genetic Polymorphisms in DNA Repair Enzymes on Drug Resistance in Lung Cancer Nancy Price, Sakkaraiappan Ramalingam, Vinay K. Jain |
|
Comprehensive Review | ||
85-98 |
Early-Stage Non–Small-Cell Lung Cancer: Current Perspectives in Combined-Modality Therapy Paul A. Bunn, Jr |
|
Original Contribution | ||
102-107 |
Gemcitabine in Patients with Non–Small-Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: A Phase II California Cancer Consortium Trial Primo N. Lara, Jr, Paul H. Gumerlock, Philip C. Mack, Derick H.M. Lau, Regina Gandour-Edwards, Martin J. Edelman, Kathy S. Albain, Lisa Y. Law, Jeff Longmate, Paul Frankel, Gayatri P. Reddy, Valerie Israel, James H. Doroshow, David R. Gandara |
|
Imaging in Lung Cancer | ||
108-112 |
Bronchioalveolar Cell Carcinoma: Radiologic Appearance and Dilemmas in the Assessment of Response Bradley S. Sabloff, Mylene T. Truong, Ignacio I. Wistuba, Jeremy J. Erasmus |
|
Translational Medicine | ||
113-122 |
Antiapoptotic Signaling Pathways in Non–Small-Cell Lung Cancer: Biology and Therapeutic Strategies Eric B. Haura, W. Douglas Cress, Srikumar Chellappan, Zhong Zheng, Gerold Bepler |
|
Brief Communication | ||
123-128 |
Gefitinib in Patients with Brain Metastases from Non–Small-Cell Lung Cancer: Review of 15 Clinical Cases Yoshinobu Namba, Takashi Kijima, Soichiro Yokota, Manabu Niinaka, Satoko Kawamura, Takeo Iwasaki, Yoshito Takeda, Hiromi Kimura, Tatsuya Okada, Toshihiko Yamaguchi, Masaru Nakagawa, Yoshitomo Okumura, Hajime Maeda, Masami Ito |
|